TCL CSOT, a global leader in display technology, is set to showcase its cutting-edge automotive display solutions at CES 2025, featuring breakthrough innovations in smart cockpit technology. The ...

Scientists at Apichope Bio Pharmaceutical Co. Ltd., Guangzhou Lianrui Pharmaceutical Co. Ltd. and Guangzhou Runlin Pharmaceutical Technology Co. Ltd. have identified proteolysis targeting chimeras ...

Highly Positive Clinical Data on Completion of Testing for First Subject Dosed Twice Daily with QRX003 in Open-Label StudyDemonstrated Clinical ...

EDP-235 is under clinical development by Enanta Pharmaceuticals and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

Chimerix submitted a new drug application to the FDA seeking accelerated approval for dordaviprone to treat patients with ...

Co. Ltd. has synthesized proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase-binding moiety covalently linked to a target protein binding moiety through a linker ...

VIR-5818 is under clinical development by Vir Biotechnology and currently in Phase II for Metastatic Breast Cancer.

Beyond Structure, Predicting Function' SHANGHAI, Dec. 25, 2024 /PRNewswire/ -- Recently, Shanghai Matwings Technology Co., Ltd. ('Matwings'), a global ...

Groundbreaking 'Whole Body' Study will be conducted by Dr. Amy Paller at Northwestern University Up to eight subjects will have QRX003 applied twice daily to greater than 80% of their body surface are ...

"Malcolm in the Middle" is making a return! The beloved family sitcom will air a limited, four-episode run on Disney+ with stars Frankie Muniz, Bryan Cranston and Jane Kaczmarek all back in their ...

“Our work establishes cap methyl transferase enzymes as therapeutic targets and opens the door to many more antiviral developments against pathogens that until now we’ve had only limited tools to ...

Product Type (Animal (Trypsin, Renin, Pepsin, Others), Plant (Papain, Keratinases, Others), Microbial (Alkaline, Acid Stable, ...